138253-26-6

Upstream product

• 17342-08-4 (S)-Pyroglutaminol 
• 138253-24-4 (S)-1-(4-Methoxy-benzyl)-5-(4-methoxy-benzyloxymethyl)-pyrrolidin-2-one 
• 138253-25-5 (S)-1-(4'-methoxybenzyl)-5-methoxymethyl-pyrrolidin-2-one 
• 152500-26-0 (S)-5-(hydroxymethyl)-1-(4-methoxyphenylmethyl)-2-pyrrolidinone 

Downstream Products

• 137664-63-2 (3aR,6R,6aR)-5-(4-Methoxy-benzyl)-6-methoxymethyl-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyrrol-4-one 
• 138253-28-8 [(R)-1-((4R,5R)-5-Benzylcarbamoyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-2-methoxy-ethyl]-carbamic acid tert-butyl ester 
• 138253-29-9 (4R,5R)-5-((R)-1-Dimethylamino-2-methoxy-ethyl)-2,2-dimethyl-[1,3]dioxolane-4-carboxylic acid benzylamide 

Relevant academic research and scientific papers

Stereoselective Synthesis of 2,3-Dihydroxy-4-dimethylamino-5-methoxypentanoic Acid, A Fragment of Calyculins - Determination of the Absolute Configuration of Calyculins

2,3-Dihydroxy-4-dimethylamino-5-methoxypentanoic acid (2) with (2R,3R,4R)-configuration has been stereoselectively prepared from (S)-pyroglutaminol (3) and revealed to be the enantiomer of the compound derived from calyculins (1), which provides the conclusicve evidence on the absolutr configuration of calyculins.